# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-23-092665
Filing Date
2023-08-16
Accepted
2023-08-16 17:19:22
Documents
24
Period of Report
2023-08-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2323971d1_8k.htm iXBRL | 8-K | 27522
2 | EXHIBIT 99.1 | tm2323971d1_ex99-1.htm | EX-99.1 | 22653
6 | GRAPHIC | tm2323971d1_ex99-1img001.jpg | GRAPHIC | 664755
7 | GRAPHIC | tm2323971d1_ex99-1img002.jpg | GRAPHIC | 657496
8 | GRAPHIC | tm2323971d1_ex99-1img003.jpg | GRAPHIC | 663899
9 | GRAPHIC | tm2323971d1_ex99-1img004.jpg | GRAPHIC | 575723
10 | GRAPHIC | tm2323971d1_ex99-1img005.jpg | GRAPHIC | 579817
11 | GRAPHIC | tm2323971d1_ex99-1img006.jpg | GRAPHIC | 477536
12 | GRAPHIC | tm2323971d1_ex99-1img007.jpg | GRAPHIC | 597051
13 | GRAPHIC | tm2323971d1_ex99-1img008.jpg | GRAPHIC | 514293
14 | GRAPHIC | tm2323971d1_ex99-1img009.jpg | GRAPHIC | 533620
15 | GRAPHIC | tm2323971d1_ex99-1img010.jpg | GRAPHIC | 567170
16 | GRAPHIC | tm2323971d1_ex99-1img011.jpg | GRAPHIC | 493900
| Complete submission text file | 0001104659-23-092665.txt |  | 8943113

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | gild-20230816.xsd | EX-101.SCH | 3009
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | gild-20230816_lab.xml | EX-101.LAB | 34240
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | gild-20230816_pre.xml | EX-101.PRE | 22355
18 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2323971d1_8k_htm.xml | XML | 3210

Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 231179103
SIC: 2836 Biological Products, (No Diagnostic Substances)